Adverse events with everolimus in BOLERO-2

Ann Oncol. 2014 Sep;25(9):1861. doi: 10.1093/annonc/mdu195. Epub 2014 May 29.

Authors

P Neven¹, A Poppe², P Berteloot², P Wolter², H Wildiers²

Affiliations

¹ Department of Oncology, Multidisciplinary Breast Center, University Hospitals Leuven, KULeuven (University of Leuven), Leuven, Belgium. Electronic address: [email protected].
² Department of Oncology, Multidisciplinary Breast Center, University Hospitals Leuven, KULeuven (University of Leuven), Leuven, Belgium.

PMID: 24875799
DOI: 10.1093/annonc/mdu195

No abstract available

Publication types

Letter
Comment

MeSH terms

Breast Neoplasms / drug therapy*
Drug-Related Side Effects and Adverse Reactions / pathology*
Female
Humans
Sirolimus / analogs & derivatives*

Substances

Sirolimus